AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports
AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports July 8 (Reuters) - Astrazeneca AZN.L and Daiichi Sankyo 4568.T are nearing a pricing agreement in the UK for their breast cancer drug Enhertu, Bloomberg News reported on Wednesday, citing multiple people familiar with the matter.
Reuters could not immediately verify the report.
(Reporting by Raechel Thankam Job in Bengaluru; Editing by Arun Koyyur)